
Myriad Genetics MYGN
€ 3.11
0.0%
Quartalsbericht 2026-Q1
hinzugefügt 06.05.2026
Myriad Genetics Langfristiger Schuldenstrom 2011-2026 | MYGN
Langfristiger Schuldenstrom Jährlich Myriad Genetics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.9 M | 12.8 M | 16.2 M | 14.1 M | 13 M | 13.6 M | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 16.2 M | 6.9 M | 12.8 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
662 K | $ 1.31 | -19.63 % | $ 1.74 M | ||
|
Castle Biosciences
CSTL
|
1.32 M | $ 19.11 | 1.19 % | $ 554 M | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 15.85 | -2.1 % | $ 479 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
79 M | $ 142.72 | -0.36 % | $ 22.7 B | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 1.8 | - | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 19.85 | -3.12 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 93.78 | -2.99 % | $ 6.33 B | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 418.32 | -0.2 % | $ 12.1 B | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
35.1 M | $ 1 038.75 | -0.3 % | $ 21.4 B | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
NeoGenomics
NEO
|
4.78 M | $ 8.29 | -0.9 % | $ 1.06 B | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 152.19 | -4.36 % | $ 7.54 B | ||
|
National Research Corporation
NRC
|
451 K | $ 18.61 | -1.69 % | $ 417 M | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
7.64 M | $ 188.15 | -4.45 % | $ 18.5 B | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 25.27 | -0.96 % | $ 24 B | ||
|
Guardant Health
GH
|
27.7 M | $ 94.27 | -4.45 % | $ 11.8 B | ||
|
Personalis
PSNL
|
6.89 M | $ 6.38 | -4.92 % | $ 569 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 116.56 | -0.45 % | $ 9.61 B | ||
|
Senseonics Holdings
SENS
|
496 K | $ 5.72 | -1.72 % | $ 239 M | ||
|
Soleno Therapeutics
SLNO
|
726 K | $ 53.0 | 0.01 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
358 K | $ 2.25 | -6.67 % | $ 5.17 M | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 252.68 | -0.53 % | $ 21 B | ||
|
Thermo Fisher Scientific
TMO
|
275 M | $ 438.85 | -2.07 % | $ 165 B | ||
|
Celcuity
CELC
|
54 K | $ 135.17 | 0.33 % | $ 6.32 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 48.65 | -8.12 % | $ 2.91 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 8.21 | -2.61 % | $ 1.78 B | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 187.55 | -0.21 % | $ 20.8 B | ||
|
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M |